Exotherme™ is a transcutaneous vascular laser, dedicated to spider veins and telangiectasias, up to 2mm of diameter, for a safe, efficient and painless treatment.
Principle The principle of the Exotherme™ laser is based on the thermal action of the laser. The transcutaneous irradiation (with a penetration of 1 to 2 mm in the tissue) causes tissue selective absorption by hemeglobin (hemoglobin is the main target of the laser).
The effect of selective photocoagulation is based on two effects:
Conversion of light energy into heat,
Coagulation of the vascular wall with collagen denaturation.
Selective photocoagulation does not cause purpura (contrary to photothermolysis).
LSO MEDICAL LSO Medical is a French company based in Loos, in the North of France and draws on a unique competence in the domain of tissue/laser interaction to develop high technology devices.
LSO Medical designs, develops, manufactures and sells lasers and disposables formedical and aesthetic applications.
In collaboration with the University of Lille and leading physicians, our team of engineers brings innovative, therapeutic and aesthetic solutions to the physicians. Our products result from scientific researches and are clinically validated for :